|

SCIENCE

Neuronal Growth Factor Receptor Protects the Sympathetic Nervous System in Alzheimer's Disease
New research casts the role of a neuronal growth factor receptor-long suspected to facilitate the toxic effects of beta amyloid in Alzheimer's disease-in a new light, suggesting the molecule actually protects the neuron in the periphery from beta amyloid-induced damage.
University College of London Study Discovers Potential Therapeutic Target for Alzheimer's
Research led by Professor Mark Pepys FRS has identified a protein known as serum amyloid P component as a possible therapeutic target in Alzheimer's disease.
Creating Ideal Neural Cells for Clinical Use
Investigators at the Burnham Institute for Medical Research have developed a protocol to rapidly differentiate human embryonic stem cells into neural progenitor cells that may be ideal for transplantation.
UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases
Scientists are reporting the strongest evidence to date that neurodegenerative diseases target and progress along distinct neural networks that normally support healthy brain function.
New Findings Resolve Long Dispute about how the Disease Might Kill Brain Cells
Recent research results clarify how small proteins called amyloid-beta peptides damage brain cell membranes, allowing extra calcium ions to enter the neurons.
Penn Scientists Use RNA to Reprogram One Cell Type into Another
By simply flooding one cell type, a nerve cell, with the an abundance of a specific type of messenger RNA from another cell type, the investigators changed a neuron into an astrocyte-like cell.
Brain Metastases Hijack Neuron-Supporting Cells to Resist Chemotherapy
Researchers have shown that brain metastases subvert astrocytes, tricking them into protecting the tumors, and that this is the important factor in resistance to chemotherapy.
TriMark Point of Care Testing Conference 2009
May 11, 2009 | San Diego, California
Enter "CONNEXON" at checkout and receive 10% off registration.
Visit here to register today.
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|